HUP0001443A3 - 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds, pharmaceutical compositions thereof and process for preparing them - Google Patents
5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds, pharmaceutical compositions thereof and process for preparing themInfo
- Publication number
- HUP0001443A3 HUP0001443A3 HU0001443A HUP0001443A HUP0001443A3 HU P0001443 A3 HUP0001443 A3 HU P0001443A3 HU 0001443 A HU0001443 A HU 0001443A HU P0001443 A HUP0001443 A HU P0001443A HU P0001443 A3 HUP0001443 A3 HU P0001443A3
- Authority
- HU
- Hungary
- Prior art keywords
- aminopyridol
- trisubstituted
- preparing
- pharmaceutical compositions
- pyrimidine compounds
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84348497A | 1997-04-16 | 1997-04-16 | |
| PCT/US1998/007201 WO1998046604A1 (en) | 1997-04-16 | 1998-04-13 | 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0001443A2 HUP0001443A2 (hu) | 2000-10-28 |
| HUP0001443A3 true HUP0001443A3 (en) | 2001-01-29 |
Family
ID=25290123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001443A HUP0001443A3 (en) | 1997-04-16 | 1998-04-13 | 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds, pharmaceutical compositions thereof and process for preparing them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0975633A1 (ja) |
| JP (1) | JP2001520654A (ja) |
| KR (1) | KR20010006462A (ja) |
| CN (1) | CN1252069A (ja) |
| AR (1) | AR012437A1 (ja) |
| AU (1) | AU741033B2 (ja) |
| BG (1) | BG103853A (ja) |
| BR (1) | BR9809056A (ja) |
| CA (1) | CA2286592A1 (ja) |
| CO (1) | CO4940470A1 (ja) |
| HU (1) | HUP0001443A3 (ja) |
| IL (1) | IL131617A0 (ja) |
| NO (1) | NO995035L (ja) |
| NZ (1) | NZ337125A (ja) |
| PL (1) | PL336265A1 (ja) |
| SK (1) | SK140099A3 (ja) |
| TR (1) | TR199902550T2 (ja) |
| WO (1) | WO1998046604A1 (ja) |
| ZA (1) | ZA983175B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001057040A1 (en) * | 2000-02-03 | 2001-08-09 | Abbott Laboratories | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| IL156872A0 (en) | 2001-02-12 | 2004-02-08 | Hoffmann La Roche | 6-substituted pyrido-pyrimidines |
| CN107744520A (zh) * | 2017-10-25 | 2018-03-02 | 南京多宝生物科技有限公司 | 嘧啶类化合物在制备促进小肠蠕动药物中的应用 |
| CN112209924B (zh) * | 2019-07-09 | 2022-04-05 | 中国科学院天津工业生物技术研究所 | 选择性腺苷a1受体拮抗剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB774094A (en) * | 1953-01-02 | 1957-05-08 | Wellcome Found | Improvements in or relating to pyrimidine compounds |
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
-
1998
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/hu unknown
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-13 IL IL13161798A patent/IL131617A0/xx unknown
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/xx unknown
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/pt not_active IP Right Cessation
- 1998-04-13 JP JP54408398A patent/JP2001520654A/ja active Pending
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/ko not_active Application Discontinuation
- 1998-04-13 SK SK1400-99A patent/SK140099A3/sk unknown
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Application Discontinuation
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 PL PL98336265A patent/PL336265A1/xx unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/zh active Pending
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-15 ZA ZA983175A patent/ZA983175B/xx unknown
- 1998-04-15 AR ARP980101734A patent/AR012437A1/es unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/es unknown
-
1999
- 1999-10-15 NO NO995035A patent/NO995035L/no not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010006462A (ko) | 2001-01-26 |
| SK140099A3 (en) | 2000-05-16 |
| JP2001520654A (ja) | 2001-10-30 |
| ZA983175B (en) | 1998-10-21 |
| AU7108098A (en) | 1998-11-11 |
| HUP0001443A2 (hu) | 2000-10-28 |
| NZ337125A (en) | 2001-06-29 |
| WO1998046604A1 (en) | 1998-10-22 |
| CN1252069A (zh) | 2000-05-03 |
| CA2286592A1 (en) | 1998-10-22 |
| AR012437A1 (es) | 2000-10-18 |
| TR199902550T2 (xx) | 2000-04-21 |
| NO995035D0 (no) | 1999-10-15 |
| AU741033B2 (en) | 2001-11-22 |
| BR9809056A (pt) | 2000-08-01 |
| PL336265A1 (en) | 2000-06-19 |
| CO4940470A1 (es) | 2000-07-24 |
| NO995035L (no) | 1999-12-15 |
| BG103853A (en) | 2000-06-30 |
| IL131617A0 (en) | 2001-01-28 |
| EP0975633A1 (en) | 2000-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0001507A3 (en) | Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0003355A3 (en) | Thieno[2,3-d]pyrimidinedione derivatives and pharmaceutical compositions containing them, process for their preparation and use thereof | |
| HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
| HUP0203450A3 (en) | Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
| HUP0002104A3 (en) | Pyrazolo[3,4-d]pyrimidinedione derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0103472A3 (en) | Pyrrolo[2,3-d]pyrimidine derivatives and pharmaceutical compositions containing the same | |
| HUP9901535A3 (en) | Aryl pyrimidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0004333A3 (en) | Novel triazolo [4,5-d] pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing thereof | |
| HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0001802A3 (en) | Pyrazine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0100394A3 (en) | 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof | |
| HUP0001539A3 (en) | 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same | |
| HUP0201122A2 (en) | Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP9800138A3 (en) | 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use | |
| IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
| HUP0002893A3 (en) | Substituted quinazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP0104199A3 (en) | Substituted pyrimido pyrimidinone derivatives, pharmaceutical compositions containing the same, process for the preparation thereof and intermediates | |
| HUP0003309A3 (en) | Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0000851A3 (en) | Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0002050A3 (en) | Substituted imidazole compounds, process for producing them, pharmaceutical compositions containing them and their use | |
| HUP0002480A3 (en) | Pyrrolo[2,1-c][1,4]benzodiazepine derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
| HUP0002902A3 (en) | 3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions |